Tags : Nathalie Landry

Viewpoints

ViewPoints Interview: Medicago’s Nathalie Landry Shares Insight on Plant-Derived Vaccine

In an interview with PharmaShots, Nathalie Landry, Executive Vice President, Scientific and Medical Affairs at Medicago shared her views on positive results of P-I clinical trial results for its plant-derived COVID-19 vaccine.  Shots: The results of the trial demonstrated that 100% of participants developed a promising antibody response after two doses of Medicago’s COVID-19 adjuvanted […]Read More